Pharmaceuticals

Precision Business Insights expertise in global pharmaceutical industry helps to navigate the vast data on pharmaceuticals, which span across different therapeutic categories and help you to make you business decisions. PBI’s seasoned analysts, consultants; Subject Matter Experts (SME) works on different aspects of pharmaceutical industry such as research and development activities, product pipeline analysis, patent analysis, product information, competitor information and many more to deliver quality and actionable insights to the clients. Our experts works with the clients to devise effective strategies to address the complex challenges of pharmaceutical industry such as patient access, regulatory bottle necks, innovations and many more. PBI’s accurate market insights help biotech and pharmaceutical companies to develop effective business strategies and provide critical market information essential to future prospects of the clients business.

The global pharmaceutical industry is experiencing significant growth across the regions. This has been majorly attributed to the rise in demand for quality healthcare, growth in healthcare infrastructure in both emerging and developed markets. Moreover, growing prevalence and incidence of several chronic and acute diseases like diabetes, cardiovascular diseases, cancer, AIDS, communicable and infectious diseases expected to create ample growth opportunities for the players operating in the market. The rising demand for innovative and efficacious drugs, rise in patent expiries has created the ample growth opportunities for generic and research driven pharmaceutical companies. The development of novel drugs, targeted therapies, and personalized medicines has opened new avenues for the market players in the industry. On the other hand, pharmaceutical industry is attracting significant investment from both private and public organizations and players in the market continuously striving to engage key stakeholders like patients, healthcare providers, and regulators to address the market access challenges in both developed and developing economies. However, regulatory bottlenecks, dearth of healthcare infrastructure, and challenges in product distribution in developing and underdeveloped economies are impeding the market growth.

Global pharmaceutical industry majorly concentrated in mature markets like U.S, developed markets of Europe, and Japan, which are exhibiting snail pace growth owing to patent expiries, lower late stage product pipeline, and stringent regulations. However, markets in emerging economies exhibit double digit growth rate due to increased access to medicines, favorable patient demographics, and availability of skilled workforce.

PBI’s Pharmaceutical Industry therapeutic area coverage Includes, but not limited:

  • Autoimmune Diseases
  • Blood and Blood related Disorders
  • Cancer
  • Cardiovascular Diseases
  • Communicable and Infectious Diseases
  • Eye Diseases
  • GIT Disease
  • Metabolic Disorders
  • Neuropsychiatric Disorders
  • Respiratory diseases
  • Skin Diseases
  • Women’s Health

Find our below list of pharmaceutical market research reports

Page 1 of 12 (572 Reports)

ImageNameDateCategoriesRegionSummaryUrltag

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX